REBIF 44 micrograms/0.5 ml, solution for injection in a cartridge 4 cartridges of 1.5 ml
Active ingredients: Interferon beta-1a
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection4 cartridges of 1.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REBIF 44 microgrammes/0,5 ml, solution injectable en cartouche
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 4 cartouche(s) en verre de 1,5 ml
- Marketing authorisation holder
- MERCK SERONO EUROPE (ROYAUME-UNI)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Dec 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62657978CIP73931472CIP133400939314723Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INTERFÉRON BÊTA-1Asolution | 132 microgrammes · 1,5 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.